Well-designed clinical trials with depression as a primary outcome measure are needed to establish whether GLP-1 agonists have genuine antidepressant properties independent of their metabolic effects
Michelle Seguin, MD Medical Reviewer Michelle Seguin, MD, is a board-certified family medicine, lifestyle medicine, and certified functional medicine physician (IFMCP)
When used for weight loss, the standard semaglutide dosing schedule calls for weekly subcutaneous injections 6
We hand-searched the included studies for other eligible ones
Our team provides individualized care to ensure the best outcomes with personalized treatment plans tailored to each patients needs
At InjectCo, we offer a physician-supervised weight loss program designed to provide structure, medical oversight, and ongoing support